INTEGRA Biosciences has introduced the SWITCH hybrid pipette, a laboratory instrument scientifically evaluated for ergonomics through collaboration with the Zurich University of Applied Sciences (ZHAW). The device combines manual pipetting control with electronic repeat dispense functionality, addressing workplace injury risks associated with repetitive laboratory tasks.
Revvity has introduced Living Image Synergy AI, a unified software platform designed to streamline preclinical imaging analysis across multiple modalities. The solution integrates artificial intelligence capabilities to enhance data analysis for in vivo imaging researchers working with optical, microCT, ultrasound, and other imaging technologies.
Siemens Healthineers has introduced the Atellica DT 250 Analyzer, a benchtop drug testing system designed to deliver clinical-quality results across diverse testing environments, from forensic laboratories to hospital settings.
Cambridge-based Abselion has introduced a Protein G Total Antibody Quantification Kit for its Amperia benchtop platform, extending the system’s analytical capabilities beyond existing Protein A-based formats. The kit enables researchers to quantify antibodies across a broader spectrum of IgG subclasses and species, addressing measurement gaps in humanised antibodies, rodent IgGs, and engineered variants.
HemostOD, a Swiss preclinical-stage company developing ex vivo manufactured universal human blood platelets, has closed a CHF 4.3 million seed extension financing round to advance pre-IND development and establish commercial-scale production capabilities. The funding round was co-led by Polytech Ventures and Orenok Holdings, with participation from the Lichtsteiner Foundation and private investors.
San Diego biotech company Replicate Bioscience has entered into a multi-year research collaboration with pharmaceutical giant Novo Nordisk to develop self-replicating RNA (srRNA) therapeutics targeting obesity, type 2 diabetes, and other cardiometabolic conditions. The partnership combines Replicate’s proprietary srRNA platform technology with Novo Nordisk’s expertise in metabolic disease to create a new class of therapeutic […]
Integrated DNA Technologies (IDT) has announced a strategic partnership with Hamilton Company to develop automated comprehensive genomic profiling workflows for cancer research and other genomic applications. The collaboration will integrate IDT’s customisable NGS research components with Hamilton’s precision liquid handling platforms.
Revvity has announced a comprehensive initiative to expand early detection capabilities for type 1 diabetes, combining in vitro diagnostic assay development with laboratory testing services in collaboration with Sanofi. The programme centres on advancing the company’s existing research-use autoantibody testing platform towards regulatory approval and broader clinical implementation.
Bio-Rad Laboratories has secured exclusive European distribution rights for Gencurix’s CE-IVD Droplex digital PCR oncology testing kits, marking a significant expansion of the companies’ existing collaboration in molecular diagnostics.
SPT Labtech and Agilent Technologies have announced the release of automated target enrichment protocols for the firefly®+ platform, designed to streamline genomic sequencing workflows in clinical research, oncology, and precision medicine applications. The protocols, which integrate Agilent’s SureSelect Max DNA Library Prep Kit with SPT Labtech’s liquid handling automation, are now available to all firefly+ […]
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.